Almac Group

Almac Group

Almac has >20 years’ experience supplying peptides to both the research community and for clinical trials. Our scientists have developed a high level of technical expertise enabling manufacture of peptides with a wide range of complexity, including high-throughput manufacture, long peptides, conjugation and peptide cocktails. Almac has intimate knowledge of all the required steps to progress a peptide radiopharmaceutical precursor from initial concept to first in human testing, and through the entire clinical journey. We have ongoing programs from Phase 0 through to Process Validation and supported a commercial radiopharmaceutical launch in 2023.

12/15/2025

Other, Pharmaceuticals, Precursors and Reference Compounds, Services